JA Cramer

1.1k total citations · 1 hit paper
14 papers, 891 citations indexed

About

JA Cramer is a scholar working on Pediatrics, Perinatology and Child Health, Family Practice and Psychiatry and Mental health. According to data from OpenAlex, JA Cramer has authored 14 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pediatrics, Perinatology and Child Health, 3 papers in Family Practice and 3 papers in Psychiatry and Mental health. Recurrent topics in JA Cramer's work include Medication Adherence and Compliance (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Epilepsy research and treatment (2 papers). JA Cramer is often cited by papers focused on Medication Adherence and Compliance (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Epilepsy research and treatment (2 papers). JA Cramer collaborates with scholars based in United States. JA Cramer's co-authors include Robert A. Rosenheck, Dennis S. Charney, Jason Thomas, Sidney S. Chang, Young June Choe, W. G. Henderson, W. Xu, R. H. Mattson, Joseph F. Collins and Peter K. K. Wong and has published in prestigious journals such as Epilepsia, Obstetrics and Gynecology and Psychiatric Services.

In The Last Decade

JA Cramer

13 papers receiving 821 citations

Hit Papers

Compliance With Medication Regimens for Mental and Physic... 1998 2026 2007 2016 1998 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
JA Cramer United States 7 651 224 213 150 114 14 891
Kristin A. Cassidy United States 19 781 1.2× 126 0.6× 227 1.1× 119 0.8× 111 1.0× 55 1000
Amy Grogg United States 13 865 1.3× 132 0.6× 201 0.9× 119 0.8× 110 1.0× 26 1.2k
Ola Granström Sweden 8 474 0.7× 42 0.2× 190 0.9× 66 0.4× 132 1.2× 13 722
Sandra L. Tunis United States 18 402 0.6× 88 0.4× 150 0.7× 19 0.1× 82 0.7× 50 879
Lynda Bryant‐Comstock United States 11 1.0k 1.6× 616 2.8× 116 0.5× 70 0.5× 34 0.3× 15 1.3k
Leah Gillon United States 14 491 0.8× 56 0.3× 289 1.4× 135 0.9× 142 1.2× 16 991
Stephan Mühlig Germany 15 153 0.2× 76 0.3× 189 0.9× 58 0.4× 117 1.0× 68 896
J. Tegeler Germany 15 817 1.3× 92 0.4× 289 1.4× 16 0.1× 90 0.8× 41 929
Ravi Lingam United Kingdom 6 377 0.6× 38 0.2× 192 0.9× 92 0.6× 96 0.8× 12 591
Kyoko Higashi Japan 7 349 0.5× 39 0.2× 145 0.7× 49 0.3× 81 0.7× 10 535

Countries citing papers authored by JA Cramer

Since Specialization
Citations

This map shows the geographic impact of JA Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JA Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JA Cramer more than expected).

Fields of papers citing papers by JA Cramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JA Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JA Cramer. The network helps show where JA Cramer may publish in the future.

Co-authorship network of co-authors of JA Cramer

This figure shows the co-authorship network connecting the top 25 collaborators of JA Cramer. A scholar is included among the top collaborators of JA Cramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JA Cramer. JA Cramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Cramer, JA, et al.. (2007). POI6 WOMEN TREATED WITH MONTHLY IBANDRONATE DEMONSTRATE IMPROVED PERSISTENCE VERSUS WEEKLY BISPHOSPHONATES. Value in Health. 10(3). A98–A98. 2 indexed citations
2.
Cramer, JA, et al.. (2007). POI7 WOMEN ARE MORE PERSISTENT WITH MONTHLY IBANDRONATE VS.WEEKLY BISPHOSPHONATES: RESULTS FROM A RETROSPECTIVE DATABASE. Value in Health. 10(3). A98–A98. 2 indexed citations
3.
Cramer, JA, Carole Bradley-Kennedy, & Alissa Scalera. (2006). PAS12 TREATMENT PERSISTENCE AND COMPLIANCE WITH MEDICATIONS FOR ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Value in Health. 9(3). A103–A103. 1 indexed citations
4.
Gold, Deborah T., et al.. (2006). Consistent Improvement In Bisphosphonate Persistence with Less Frequent Dosing: Review Comparing Results of Three Database Studies. Journal of Clinical Densitometry. 9(3). 382–382.
5.
Cramer, JA & Brian J. Cuffel. (2005). PNL19 DEVELOPMENT OF THE MULTIPLE SCLEROSIS TREATMENT SATISFACTION QUESTIONNAIRE (MSTCQ). Value in Health. 8(3). 320–320. 1 indexed citations
6.
Burrell, Anita, Peter K. K. Wong, Daniel A. Ollendorf, et al.. (2005). PHP46 DEFINING COMPLIANCE/ADHERENCE AND PERSISTENCE: ISPOR SPECIAL INTEREST WORKING GROUP. Value in Health. 8(6). A194–A195. 20 indexed citations
9.
Rosenheck, Robert A., Sidney S. Chang, Young June Choe, et al.. (2000). Medication continuation and compliance: a comparison of patients treated with clozapine and haloperidol.. PubMed. 61(5). 382–6. 72 indexed citations
10.
Cramer, JA. (1999). Practical issues in medication compliance. Transplantation Proceedings. 31(4). 7S–9S. 15 indexed citations
11.
Cramer, JA & Robert A. Rosenheck. (1998). Compliance With Medication Regimens for Mental and Physical Disorders. Psychiatric Services. 49(2). 196–201. 566 indexed citations breakdown →
12.
Cramer, JA. (1996). Compliance With Contraceptives and Other Treatments. Obstetrics and Gynecology. 88(3). 4S–12S. 49 indexed citations
13.
Mattson, R. H., JA Cramer, & Joseph F. Collins. (1988). Aspects of compliance: taking drugs and keeping clinic appointments.. PubMed. 1. 111–7. 12 indexed citations
14.
Mattson, R. H., et al.. (1982). Medroxy progesterone treatment of women with uncontrolled seizures. Epilepsia. 23(4). 436–437. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026